.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Merck
Cerilliant
Moodys
Federal Trade Commission
Cipla
Accenture
Harvard Business School
McKesson
QuintilesIMS

Generated: September 23, 2017

DrugPatentWatch Database Preview

Riociguat - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for riociguat and what is the scope of riociguat freedom to operate?

Riociguat
is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Riociguat has seventy-five patent family members in forty-three countries.

There are two drug master file entries for riociguat. One supplier is listed for this compound.

Summary for Generic Name: riociguat

Tradenames:1
Patents:2
Applicants:1
NDAs:1
Drug Master File Entries: see list2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list43
Clinical Trials: see list30
Patent Applications: see list111
Drug Prices:see low prices
DailyMed Link:riociguat at DailyMed

Pharmacology for Ingredient: riociguat

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare
ADEMPAS
riociguat
TABLET;ORAL204819-005Oct 8, 2013RXYesYes► Subscribe► Subscribe► Subscribe
Bayer Hlthcare
ADEMPAS
riociguat
TABLET;ORAL204819-001Oct 8, 2013RXYesNo► Subscribe► SubscribeYY ► Subscribe
Bayer Hlthcare
ADEMPAS
riociguat
TABLET;ORAL204819-005Oct 8, 2013RXYesYes► Subscribe► SubscribeYY ► Subscribe
Bayer Hlthcare
ADEMPAS
riociguat
TABLET;ORAL204819-002Oct 8, 2013RXYesNo► Subscribe► SubscribeYY ► Subscribe
Bayer Hlthcare
ADEMPAS
riociguat
TABLET;ORAL204819-002Oct 8, 2013RXYesNo► Subscribe► SubscribeYY ► Subscribe
Bayer Hlthcare
ADEMPAS
riociguat
TABLET;ORAL204819-004Oct 8, 2013RXYesNo► Subscribe► SubscribeYY ► Subscribe
Bayer Hlthcare
ADEMPAS
riociguat
TABLET;ORAL204819-002Oct 8, 2013RXYesNo► Subscribe► Subscribe► Subscribe
Bayer Hlthcare
ADEMPAS
riociguat
TABLET;ORAL204819-005Oct 8, 2013RXYesYes► Subscribe► Subscribe► Subscribe
Bayer Hlthcare
ADEMPAS
riociguat
TABLET;ORAL204819-003Oct 8, 2013RXYesNo► Subscribe► Subscribe► Subscribe
Bayer Hlthcare
ADEMPAS
riociguat
TABLET;ORAL204819-001Oct 8, 2013RXYesNo► Subscribe► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: riociguat

Country Document Number Estimated Expiration
Germany59912966► Subscribe
World Intellectual Property Organization (WIPO)03095451► Subscribe
Norway20045277► Subscribe
Slovakia1302001► Subscribe
Australia5284099► Subscribe
Uruguay27793► Subscribe
China1330649► Subscribe
China1317005► Subscribe
Japan4455321► Subscribe
Hong Kong1040712► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: RIOCIGUAT

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2014018,C1506193Lithuania► SubscribePRODUCT NAME: RIOCIGUATUM; REGISTRATION NO/DATE: EU/1/13/907/001 - EU/1/13/907/015 20140327
419Luxembourg► SubscribePRODUCT NAME: RIOCIGUAT ET SES DERIVES PHARMACEUTIQUEMENT ACCEPTABLES(ADEMPAS)
2014 00028Denmark► SubscribePRODUCT NAME: RIOCIGUAT OG SALTE, ISOMERER OG HYDRATER HERAF; REG. NO/DATE: EU/1/13/907 20140327
400019Hungary► SubscribePRODUCT NAME: RIOCIGUAT; REG. NO/DATE: EU/1/13/97 20140327
0140015 00109Estonia► SubscribePRODUCT NAME: RIOTSIGUAAT;REG NO/DATE: K(2014)2152 (LOPLIK) 31.03.2014
14/028Ireland► SubscribePRODUCT NAME: RIOCIGUAT OR A SALT, ISOMER OR HYDRATE THEREOF; REGISTRATION NO/DATE: EU/1/13/907/001-015 20140327
1506193/01Switzerland► SubscribePRODUCT NAME: RIOCIGUAT; REGISTRATION NO/DATE: SWISSMEDIC 62903 21.11.2013
5 5014-2014Slovakia► SubscribePRODUCT NAME: RIOCIGUAT; REGISTRATION NO/DATE: EU/1/13/907 20140327
0659Netherlands► SubscribePRODUCT NAME: RIOCIGUAT, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF HYDRAAT; REGISTRATION NO/DATE: EU/1/13/907 20140331
/2014Austria► SubscribePRODUCT NAME: RIOCIGUAT; REGISTRATION NO/DATE: EU/1/13/907 20140331
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Fish and Richardson
Dow
Moodys
McKesson
Julphar
Express Scripts
Cipla
Queensland Health
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot